Established in 1997, Eva Pharma is one of Egypt's leading pharmaceutical companies, built on the heritage of Les Laboratoires Delta, Egypt's second oldest pharmaceutical company. Today, Eva Pharma is the fastest growing pharmaceutical company in the MENA region, growing at a rate of more than 30% CAGR (compound annual growth rate) for the past seven years; transforming from a successful local company into a world class multinational organization, with a sales and marketing presence across the region. Eva Pharma is an active contributor to the on-going drug industry in Egypt, North Africa and the Middle East, with huge market participation. Currently, Eva Pharma consists of a team of 2811 loyal staff and produces an average 350,000 effective and affordable packs of medicine daily from 137 different products. All their products are stamped by several recognized quality seals and the Eva Pharma logo which, due to their exacting quality standards, acts as their own stamp of approval.
Vision
Empower the fight for health and wellbeing as a Human right
Mission:
To save and improve millions of lives in Africa and frontier markets by offering accessible, high quality branded medicines that meet specific local market needs through innovative research & product development, a passionate diverse top team and state of the art scale facilities.
Values:
Their Values At Eva Pharma they pride themselves on their core values and ethics that have guided their growth and helped position them as one of the most trusted providers of healthcare products in Egypt and the region. The founding pillars of their philosophy, is to improve people's lives by honoring their core values: - Customer First - Ownership - Passion for Success - Honesty - Fairness - Respect - Positive Impact.
Research & Development
At Eva Pharma, they see R&D as more than just a process by which they develop new drugs and launch them into the market. Their approach to creating and launching new drugs is a multi-faceted one a research based creative process designed to make available the most needed drugs that make the most impact.
Their product pipeline ideas are carefully reviewed by a committee comprising Department Heads and Consultants, who are considered innovators in their diverse therapeutic fields. Ideas are carefully scrutinized according to a set of criteria that covers different aspects of the product, market and community, for the express purpose of introducing drugs that are safe and fulfill the needs and deficiencies in the market.
The guiding principle by which they operate at Eva Pharma is not about replicating a product, but rather to find ways to enhance its effectiveness through constantly searching for novel drug delivery systems that may add to the potentials of the product. Aside from sourcing the highest quality APIs for their product array, they also put to optimal use the valuable molecular diversity present in raw materials and exploring and isolating single entities from natural products that can be used for new products addressing different therapeutic needs on the local and global healthcare theatre.
To Date, Eva Pharma’s R&D is responsible for 133 products in the market and over 270 prospective products currently in the pipeline. They achieve their mandate of excellence by means of regularly upgrading their R&D laboratories and facilities with specialized equipment and state-of-the-art instruments, while carefully selecting exceptionally skilled professionals to operate them. They share in shaping the future ofpharmaceutical research through implementing the latest cutting-edge technologies and innovations.
